On January 10, 2023, Kirsten Flowers notified Kura Oncology, Inc. (the âCompanyâ) of her intention to resign from her position as the Companyâs Chief Commercial Officer, effective as of January 27, 2023 (the âSeparation Dateâ), in order to pursue other opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.59 USD | +0.44% | -1.67% | +43.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.18% | 1.57B | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kirsten Flowers Notifies Kura Oncology, Inc. of Resignation as Chief Commercial Officer